ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 758027 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 758027; 2) Community: the network communities that were significantly associated with the response to NSC 758027; 3) Molecule: the relationships between components within communities and NSC 758027; 4) MDR: the compounds that were significantly associated with the NSC 758027.

NSC Compound Enrichment Correlation
NSC 717953 Null 0.0392716453377535 0.19788316
NSC 718781 Erlotinib hydrochloride 0.0392716453377535 -0.27859686
NSC 720134 Null 0.0392716453377535 -0.17161157
NSC 720495 Null 0.0392716453377535 0.39572062
NSC 726217 Combretastatin A4-analogue 0.0392716453377535 0.38305771
NSC 727620 6-[3-(2-Aminoethylamino)]-bis{1-propyl)-5,6-dihydro-2,3-dime thoxy-8,9-methylenedioxy-5,11-dioxo-11H-indeno[1,2-c]isoquin oline} dihydrochloride 0.0392716453377535 0.016231096
NSC 730009 cis-2,5,6,12,13-Pentahydro-6-methyl-(8,9-methylenedioxy)-3-n itro-5,11-dioxo-11H-indeno[1,2-c]isoquinoline 0.0392716453377535 0.25721855
NSC 732205 Null 0.0392716453377535 0.2218857
NSC 732962 5-amino-4-(1,3-benzothiazol-2-yl)-1-(2-chloro-5-trifluoromet hylphenyl)-2,3-dihydro-1H-3-pyrrolone 0.0392716453377535 0.33145563
NSC 734949 4-[3-(3,4-dihydro-1H-isoquinolin-2-yl)prop-1-en-2-yl]-N-pyrazin-2-ylbenzamide 0.0392716453377535 0.44387864
Total:82  Current:68    [First] [Prev] [Next] [Last]